FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

33365411000001109: Quinagolide 25microgram tablets (Aspire Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 14-Sep 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
100756901000001112 Quinagolide 25microgram tablets (Aspire Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100757001000001111 Quinagolide 25microgram tablets (Aspire Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Quinagolide 25microgram tablets (Aspire Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) Is a Quinagolide 25microgram tablets true Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) Has active ingredient Quinagolide true Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) VMP prescribing status (attribute) VMP invalid as a prescribable product true Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) Has specific active ingredient Quinagolide hydrochloride false Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Quinagolide true Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) Has basis of strength substance Quinagolide true Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) Has specific active ingredient Quinagolide hydrochloride true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Quinagolide 25microgram tablets (Aspire Pharma Ltd) 3 tablet Has AMP True Quinagolide 25microgram tablets (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start